JNJ Leadership & Board

CEO since January 2022, Chairman since January 2023. Leads ~138,000 employees globally, directing an R&D portfolio of nearly $17B annually across pharmaceuticals and MedTech.

Oversees global finance, capital markets and investor relations. Maintains AAA-equivalent balance sheet with net debt-to-EBITDA under 1.5x.

Leads commercial strategy for ten blockbuster therapies generating ~$57B in sales across oncology, immunology, neuroscience, and cardiology.

Runs $30B+ medical-technology portfolio spanning 300+ platforms and 8,000 patents, including surgical robotics and AI-guided endoscopy.

M.D., Ph.D. Directs end-to-end drug discovery pipeline with 105 clinical assets including 40 in Phase 3. Integrates AI-enabled research and 400 academic/biotech partners.

Leads corporate marketing, communications, health-equity initiatives and philanthropy across 100+ markets.

Heads worldwide legal, compliance, privacy and ESG. Manages complex litigation including 63,000+ talc-related claims.

Crafts global talent strategy for 134,500+ employees. Women constitute 45% of global workforce and 50% of Executive Committee seats.

Orchestrates digital strategy, cybersecurity and cloud platforms. Oversees $3B tech budget securing 15 petabytes of clinical and supply-chain data.

Governs global supply chain delivering 80 billion doses/devices annually with 98% on-time service across 150 countries.

Chair of Science & Technology Committee. Distinguished Professor of Biology and Oncological Sciences.

Nobel Prize-winning biochemist and co-inventor of CRISPR-Cas9 gene editing. Member of Science & Technology and Nominating & Corporate Governance Committees.

Chair of Nominating & Corporate Governance Committee. Former Chairman, President and CEO of Lockheed Martin.

Member of Nominating & Corporate Governance and Science & Technology Committees. President of Wellesley College.

Chair of Audit Committee. Former Chairman and CEO of Best Buy. Member of Nominating & Corporate Governance Committee.

Member of Regulatory Compliance & Sustainability and Science & Technology Committees. Former FDA Commissioner.

Member of Audit and Compensation & Benefits Committees. Former Chairman, President and CEO of Sherwin-Williams.

Member of Audit and Compensation & Benefits Committees. President and COO of JPMorgan Chase.

Chair of Regulatory Compliance & Sustainability Committee. Member of Audit Committee. Former Global Chairman and CEO of EY.

Chair of Compensation & Benefits Committee. President and CEO of Advocate Health, one of the largest nonprofit health systems in the US.

Member of Regulatory Compliance & Sustainability and Science & Technology Committees. Retired Lieutenant General and former US Army Surgeon General.